Intervention

goserelin acetate

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 34 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials34

Recruiting0

Common conditions18

Lead sponsors shown15

Clinical trials

34 shown

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerNCT02278185 · 2015-11-11

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)NCT02742675 · 2015-09-01

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate CancerNCT02058706 · 2014-05-01

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12

ACTIVE_NOT_RECRUITING

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerNCT01368263 · 2011-09-01

Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate CancerNCT01023061 · 2010-03-01

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryNCT00541047 · 2007-11-01

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerNCT00512668 · 2007-09-01

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerNCT00423475 · 2006-10-01

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryNCT00398489 · 2006-10-01

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate CancerNCT00454571 · 2006-06-01

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerNCT00348998 · 2006-04-01

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerNCT00217659 · 2005-09-01

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerNCT00104715 · 2004-10-18

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast CancerNCT00427245 · 2004-08-01

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerNCT00068601 · 2003-10-01

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerNCT00067015 · 2003-05-01

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerNCT00053911 · 2002-11-01

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate CancerNCT00653757 · 2002-03-01

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerNCT00026377 · 2001-11-01

Combination Chemotherapy in Treating Women With Breast CancerNCT00047099 · 2001-08-01

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerNCT00021450 · 2001-04-01

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerNCT00014586 · 2001-01-01

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast CancerNCT00010010 · 2000-06-01

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerNCT00031850 · 2000-03-01

Combination Chemotherapy in Treating Patients With Advanced Prostate CancerNCT00003394 · 1998-04-01

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerNCT00002881 · 1996-10-01

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate CancerNCT00002651 · 1995-05-01

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate CancerNCT00769548 · 1995-04-01

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerNCT00002580 · 1993-06-01

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerNCT00002582 · 1993-06-01

Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerNCT00002460 · 1987-09-01

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate CancerNCT00849082 · 1987-05-01

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerNCT00767286

Common conditions

Prostate Cancer16 Breast Cancer12 Adenocarcinoma of the Prostate4 Recurrent Prostate Cancer4 Stage IV Prostate Cancer3 Infertility2 Menopausal Symptoms2 Stage III Prostate Cancer2 Estrogen Receptor-positive Breast Cancer1 Gastrointestinal Complications1 HER2-negative Breast Cancer1 Sexual Dysfunction1 Stage II Breast Cancer1 Stage II Prostate Cancer1 Stage IIIA Breast Cancer1 Stage IIIB Breast Cancer1 Stage IIIC Breast Cancer1 Urinary Complications1

Leading sponsors

SWOG Cancer Research Network 4 European Organisation for Research and Treatment of Cancer - EORTC 3 UNICANCER 3 Institute of Cancer Research, United Kingdom 2 Memorial Sloan Kettering Cancer Center 2 National Cancer Institute (NCI) 2 Radiation Therapy Oncology Group 2 Anglo Celtic Cooperative Oncology Group 1 Barbara Ann Karmanos Cancer Institute 1 Cancer Research UK 1 Eastern Cooperative Oncology Group 1 Fudan University 1 Ludwig-Maximilians - University of Munich 1 Mayo Clinic 1 NYU Langone Health 1

Trial status mix

COMPLETED24

TERMINATED4

UNKNOWN4

ACTIVE_NOT_RECRUITING1

WITHDRAWN1

Phase mix

PHASE319

PHASE212

PHASE14

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.